The African Hepatitis B Advocacy Coalition (ABAC) works directly with community-based organizations across Africa to amplify their abilities to serve their respective communities. Through a competitive process, when available, the African Hepatitis B Alliance Coalition (ABAC) will provide funding through catalytic community grants to support the goals and objectives of the coalition. Funding in 2025 will launch with the LOI survey on World Hepatitis Day, July 28, 2025. LOI submissions are due by September 7.
Through the ABAC Community Catalyst Grants, community-based organizations are provided funding and capacity building support to deepen their community impact, strengthen their sustainability, and expand their services which should be centered on the following priority health needs related to hepatitis B elimination:
The funding process is described in detail below.
The LOI survey will serve as an initial screening tool to gather preliminary information from potential grantees, ensuring that applicants meet the basic criteria for the grant program. To be eligible for an award you must be an organization based in the African continent working on hepatitis B elimination activities. The LOI submission opens on July 28 and deadline is September 7. Grants will occur over a 12 month project period and include mentorship and technical assistance from the Hepatitis B Foundation.
LOI Survey components include:
After reviewing the LOI responses, only those that align well with the ABAC mission and goals will be invited to submit a more detailed application for funding. The African Advisory Group will provide recommendations on the applications to move forward.
Selection Criteria for Invitations:
Once applicants are invited, they will be asked to fill out a detailed application form that includes the following:
Application Form Sections:
Join the effort to eradicate Hepatitis B in Africa. Your contributions can empower communities, provide key resources, and save lives. Whether you donate, partner, or volunteer, your support is invaluable in paving the way for a hepatitis-free future.